We are live on ! Find out more
AAM

Azzad Asset Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 38.47%
This Fund
S&P 500
This Quarter Est. Return
-14.28%
1 Year Est. Return
+38.47%
3 Year Est. Return
+100.53%
5 Year Est. Return
+132.43%
10 Year Est. Return
+597.52%
AUM
$1.01B
AUM Growth
+$317M
Cap. Flow
+$522M
Cap. Flow %
51.6%
Top 10 Hldgs %
15.21%
Holding
411
New
89
Increased
282
Reduced
15
Closed
18

Top Sells

Rank Stock Value
1
COHR icon
Coherent
COHR
+$2.71M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.16M
3
MIDD icon
Middleby
MIDD
+$1.97M
4
DXCM icon
DexCom
DXCM
+$1.71M
5
SMG icon
ScottsMiracle-Gro
SMG
+$1.18M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Healthcare 15.18%
3 Industrials 12.56%
4 Consumer Discretionary 10.68%
5 Consumer Staples 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFX icon
126
Teleflex
TFX
$6.05B
$2.89M 0.29%
9,822
+4,060
+70% +$1.18M
TWTR
127
DELISTED
Twitter, Inc.
TWTR
$2.87M 0.28%
89,338
+62,254
+230% +$2.67M
SAP icon
128
SAP
SAP
$212B
$2.77M 0.27%
26,016
+9,116
+54% +$911K
BMY icon
129
Bristol-Myers Squibb
BMY
$133B
$2.75M 0.27%
35,849
-5,531
-13% -$421K
CPRT icon
130
Copart
CPRT
$27B
$2.71M 0.27%
112,640
+58,620
+109% +$1.67M
DPZ icon
131
Domino's
DPZ
$11.5B
$2.69M 0.27%
7,000
+2,010
+40% +$744K
NEE icon
132
NextEra Energy
NEE
$181B
$2.59M 0.26%
33,427
-6
-0% -$457
UNP icon
133
Union Pacific
UNP
$174B
$2.59M 0.26%
13,470
+6,597
+96% +$1.5M
O icon
134
Realty Income
O
$59.6B
$2.57M 0.25%
39,111
+15,815
+68% +$1.09M
CSCO icon
135
Cisco
CSCO
$457B
$2.52M 0.25%
56,832
+25,691
+82% +$1.23M
GRMN
136
Garmin
GRMN
$56.7B
$2.51M 0.25%
25,556
+6,010
+31% +$633K
NTAP icon
137
NetApp
NTAP
$35B
$2.5M 0.25%
46,485
+26,296
+130% +$1.89M
ACN icon
138
Accenture
ACN
$102B
$2.48M 0.25%
8,942
+2,590
+41% +$778K
ADM icon
139
Archer Daniels Midland
ADM
$38.2B
$2.43M 0.24%
31,424
-7
-0% -$612
TJX icon
140
TJX Companies
TJX
$174B
$2.43M 0.24%
45,034
+15,866
+54% +$960K
WST icon
141
West Pharmaceutical
WST
$24B
$2.4M 0.24%
7,927
-40
-0.5% -$13K
VEEV icon
142
Veeva Systems
VEEV
$33.1B
$2.38M 0.24%
10,952
+6,753
+161% +$1.24M
AEM icon
143
Agnico Eagle Mines
AEM
$73.6B
$2.38M 0.24%
51,943
+1,514
+3% +$84.2K
MORN icon
144
Morningstar
MORN
$7.22B
$2.35M 0.23%
9,728
+77
+0.8% +$19.4K
DD icon
145
DuPont de Nemours
DD
$18.5B
$2.31M 0.23%
33,156
+7,981
+32% +$653K
BILL icon
146
BILL Holdings
BILL
$4.49B
$2.3M 0.23%
20,880
-28
-0.1% -$4.08K
MRVL icon
147
Marvell Technology
MRVL
$168B
$2.29M 0.23%
+52,709
New +$2.99M
TXN icon
148
Texas Instruments
TXN
$252B
$2.28M 0.23%
15,838
+6,033
+62% +$1.01M
VRSN icon
149
VeriSign
VRSN
$26.2B
$2.28M 0.23%
+11,048
New +$2.03M
TT icon
150
Trane Technologies
TT
$100B
$2.27M 0.22%
22,833
+17,125
+300% +$2.37M

Similar funds

Azzad Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Azzad Asset Management held 411 positions worth $1.01B, up 46% from $694M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Azzad Asset Management deployed $522M of net new capital in Q2 2022, opening 89 new positions and adding to 282 existing holdings. Its largest new stake was Dollar General: 17,900 shares worth $3.43M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was DexCom, an estimated $1.71M trimmed.

  • Azzad Asset Management's largest Q2 2022 buy was Dollar General: 17,900 shares worth $3.43M.
  • Azzad Asset Management added most to Microsoft in Q2 2022, an estimated $15M increase.
  • Azzad Asset Management's biggest Q2 2022 reduction was DexCom, cutting an estimated $1.71M.
  • Azzad Asset Management fully exited Coherent in Q2 2022, selling an estimated $2.71M.
  • Azzad Asset Management's ten largest holdings make up 15% of its $1.01B portfolio in Q2 2022.
  • Azzad Asset Management opened 89 new positions and closed 18 in Q2 2022.
  • Azzad Asset Management's portfolio value rose 46% quarter-over-quarter to $1.01B.

Based on Azzad Asset Management's 13F filing for Q2 2022, filed 1 Apr 2024.